All Posts
Blog

Cardiology Consultants of Philadelphia Preserves Its Independence Through a Physician-Led Cardiovascular Platform

Published on August 28, 2026

Cardiology Consultants of Philadelphia (CCP), the largest independent cardiology practice in the country with over 90 physicians across five counties, joined Cardiovascular Logistics (CVL) in May 2025. One year in, CCP maintained its 21-member board, achieved roughly 90% income recovery, opened a new ambulatory surgery center, and launched its first cardiac walk-in clinic.

The Challenge: Protecting Independence in Growth

Cardiology Consultants of Philadelphia (CCP) started as a four-physician practice in the 1990s. Through mergers with like-minded groups across the Greater Philadelphia region, it grew into the largest independent cardiology practice in the country, with over 90 physicians spanning five counties, governed by a 21-member board elected from each division.

Growth at that scale creates its own tension. Medicine trains physicians toward precision and repetition, not disruption, and CCP’s leadership knew that any conversation about joining a national platform would spark skepticism from physicians who had built their careers on independence.

Physicians voiced concern about losing control over clinical decisions. Many had seen colleagues at other practices absorbed into hospital systems, promised no change, and found their day-to-day practice altered anyway.

Dr. Mark Victor, CEO of CCP, explained: “The perception was that there’s going to be a complete lack of control — that what was comfortable and transparent in CCP would suddenly become non-obvious and completely opaque, and that people outside of medicine would get in the way of patient care. That was the number-one fear.”

The Solution: A Partner Willing to Work at CCP’s Pace

CCP’s leadership had spent years comparing notes with other independent-practice CEOs across the country, including David Konur, then-CEO of Cardiovascular Institute of the South, long before CVL existed. This history gave CCP a different starting point than a cold search process would have. When Konur told Dr. Victor about the platform, the conversation was rooted in a relationship, not a pitch.

Dr. Victor brought the question to the board, then shared information with each division, ensuring every physician understood the discussion and its parameters.

What mattered most to CCP was how the platform would operate after signing. Dr. Victor drew a distinction between platforms that impose a fixed playbook and those that take the time to understand a market before recommending changes. “We use the surgical approach, not the wrecking-ball approach,” he said. “We take a lot of time to look at the local story, the local factors, before making decisions about changes or new initiatives.”

The Choice: Joining a Platform CCP Helped Shape 

CCP joined CVL in May 2025. CCP kept its 21-member board and seven-person executive committee intact, with no restructuring to match a standard model. CVL’s leadership questioned whether a larger board could act decisively, but a year of joint board meetings showed that a board’s effectiveness depends on the scope of its authority, not size.

CVL adapted to CCP’s structure instead of replacing it, an early signal of how the partnership would work.

The Process: Planning for Income Recovery from Day One 

CCP entered the partnership with a plan for income recovery, which rebuilds physician compensation after a transaction generates value. They began identifying efficiency and revenue opportunities in the months before the partnership was finalized.

That early planning shaped the first year in several areas:

• Coordinated procurement across CVL affiliates to negotiate national vendor pricing

• Shared clinical and operational best practices with other affiliate practices through monthly CEO meetings and cross-practice subspecialist councils

• Adopted a proven walk-in clinic model rather than building one from scratch

• Maintained physician-led clinical decision-making, with no change to how or when physicians practiced

The Results: Measurable Recovery and Platform-Wide Contribution

CCP’s first year delivered gains for the practice and contributions to CVL’s other affiliates:

• Achieved approximately 90% income recovery, with two divisions on pace for full recovery in 2026

• Secured platform-wide procurement pricing on equipment like wearable arrhythmia monitors, at rates no single practice could have negotiated alone

• Launched CCP Now, a walk-in cardiology clinic adapted from a model first built at CVL affiliate, Capital Cardiology Associates, in upstate New York

• Shared CCP’s six-year record of value-based Medicaid contracting success with CCA, helping them renegotiate a stalled managed-Medicaid agreement

• Originated CVL’s first platform-wide clinical research study backed by a pharmaceutical partner

• Preserved its 21-member board and seven-person executive committee

At CCP’s spring retreat, one year after joining CVL, leadership polled the room, and all 80 physician attendees confirmed they had experienced no outside direction over clinical decision-making. “Everybody was frank that they had no inkling of somebody else outside the room telling them how to practice, when to practice, how much to practice,” Dr. Victor said, “and felt confident we had made the right choice for patient care.”

Looking Ahead: New Sites of Care and AI-Enabled Practice

CCP’s second year builds directly on the infrastructure gains of its first. In June 2026, CCP opened the Ambulatory Cardiovascular Center of Pennsylvania in Wayne, Pennsylvania, a 12,500-square-foot, $8.6 million ambulatory surgery center built with CVL, SCA Health, and Penn Medicine. The facility gives CCP patients access to select cardiovascular procedures in a lower-cost outpatient setting.

CCP Now is expanding, with a second site in Lansdale opening in September 2026, and two additional locations planned for early 2027. CCP is also expanding its use of AI to make care more efficient. They apply AI-driven coronary CTA with plaque analysis to sharpen diagnosis and treatment planning, and are testing an AI-powered clinical assistant to give physicians more support at the point of care without changing who makes clinical decisions.

Interested in Joining a Leading Cardiovascular Platform?

If your practice wants to stay competitive, preserve its independence, and build the infrastructure to grow, consider partnering with Cardiovascular Logistics. Schedule a conversation to learn how joining CVL can provide the resources, autonomy, and collaborative opportunities your practice needs to thrive.


FAQs 

  • Why did Cardiology Consultants of Philadelphia join Cardiovascular Logistics?

    CCP wanted the negotiating power, technology, and shared resources of a larger platform without losing physician-led governance. Years of trust in CVL’s leadership, built through collaboration long before any transaction, gave CCP confidence CVL would work within its existing structure. CCP joined CVL in May 2025.

  • Did CCP lose governance control by joining CVL?

    No. CCP maintained its 21-member board and seven-person executive committee after joining CVL. CVL’s leadership concluded that a board’s authority matters more than its size, so CCP’s existing structure stayed in place. At a company-wide retreat one year in, 80 physicians confirmed no outside party had directed their clinical decisions.

  • What results did CCP see in its first year with CVL?

    CCP achieved roughly 90% income recovery in its first year, with two divisions on pace for full recovery in 2026. The practice also gained platform-wide procurement pricing on equipment like wearable arrhythmia monitors, launched a walk-in clinic model, and contributed the first CVL-wide clinical research study backed by a pharmaceutical partner.

  • How has CCP contributed to the CVL network of cardiology practices?

    CCP adopted its walk-in clinic model, CCP Now, from a concept first developed at CVL affiliate Capital Cardiology Associates. CCP also shared its six-year track record in value-based Medicaid contracting to help CCA renegotiate a stalled managed-Medicaid agreement, and originated CVL’s first platform-wide pharma-backed research study.

  • What’s next for CCP as part of the CVL platform?

    CCP is expanding CCP Now beyond its Springfield location, opening a Lansdale site in September 2026 with two more locations planned for early 2027. The practice also opened the Ambulatory Cardiovascular Center of Pennsylvania in June 2026, a partnership with CVL, SCA Health, and Penn Medicine, and is testing AI-powered tools for clinical efficiency.

Cardiovascular Logistics logo
Cardiovascular Logistics